A Phase III, Double-blind Randomized Group Study to Compare the Protective Immune Response to Older Adults after Immunization with either Engerix-B HBV Vaccine of Recombinant HBV Surface Antigen Co-administered with Dynavax Immunostimulatory Phosphotionat